1/2 /3-4/ 5-9/Aa-Am/An-Az/B/Ca-Ce/Cf-Cz/Da-Dh/Di-Dz/E/F/G/H/I/J/K/L/M/N/O/Pa-Pf/ /Pj-Po/Pp-Pz/Q/R/Sa-Ss/St-y/Ta-Th/Ti-Tz/U/V/W/X/Y/Z / Chinese spelling
|
|
 |
offer you
better services | |
|
DIHYDROARTEMISININ (DHA) |
|||
| Structure: C15H24O5
Molecular weight: 284.4 Chemical name: Chemical characteristics: The product exists as a mixture
of a
and b
epimers.  Lipophilyc substance : Practically insoluble in water; slightly soluble in acetonitrile, soluble in ethanol and dichloromethane. Description: Colourless needles or a white, crystalline powder. Melting point: about 140
.
Category: Antimatarial.
Storage: Dihydroartemisinin should be kept in a
well-closed container, protected from light and stored in a cool
place.
Requirements: Dihydroartemisinin contains not less than
98.0% and not more than the equivalent of 102.0% of C15H
|
|||
| Applications | |||
| Packing &loading | |||
|
This
data is only for your information purposes and does not imply guarantee
for a certain application. Please note: We do not deliver the product to private users! |
|||
| If you need an indicative price to your country, please kindly advise the annual quantity needed, destination port and we will send you our soonest CNF(Cost + Freight) price. Your indication for a workable price level will sure speed up our fastest service for you | |||
|
We really need to get
feed back from our customers in order to improve our performances. Best regards from SHENZHEN , China Mr. JEFFERY TSUI |
|||
| Material Safety Data Sheet | |||
| Related Information and Materials | |||
| A comparison of three different dihydroartemisinin formulations for the treatment of acute uncomplicated falciparum malaria in Thailand | |||
| Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria | |||
| A Clinical Trial of Dihydroartemisinin for the Treatment of Acute Uncomplicated Falciparum Malaria in Thailand : A Comparison of 3 Different Formulations | |||
 |
|||
| If the above information doesn't cover | |
contact us
| |
